These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30344955)

  • 21. The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.
    Panagiotou A; Trendelenburg M; Osthoff M
    Front Immunol; 2018; 9():1151. PubMed ID: 29910807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction?
    Heper G; Korkmaz ME; Kilic A
    Angiology; 2007 Dec-2008 Jan; 58(6):663-70. PubMed ID: 17989422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy.
    San-Martín-Martínez D; Serrano-Lemus D; Cornejo V; Gajardo AIJ; Rodrigo R
    Clin Pharmacokinet; 2022 Sep; 61(9):1203-1218. PubMed ID: 35871676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The impact of oxidative stress on myocardial reperfusion: alternative evidence].
    Balasanian MO; Haret R; Arsenescu-Georgescu C; Căruntu ID
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1162-8. PubMed ID: 22276464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction.
    Bartorelli AL
    Am J Cardiovasc Drugs; 2003; 3(4):253-63. PubMed ID: 14728078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.
    Ambrosio G; Zweier JL; Jacobus WE; Weisfeldt ML; Flaherty JT
    Circulation; 1987 Oct; 76(4):906-15. PubMed ID: 2820615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective approaches against myocardial ischemia reperfusion injury.
    Li X; Liu M; Sun R; Zeng Y; Chen S; Zhang P
    Exp Ther Med; 2016 Dec; 12(6):3823-3829. PubMed ID: 28101167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of myocardial "stunning".
    Bolli R; Hartley CJ; Rabinovitz RS
    Cardiovasc Drugs Ther; 1991 Oct; 5(5):877-90. PubMed ID: 1756133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Membrane Permeability Inhibitors in Acute Myocardial Infarction: Still Awaiting Translation.
    Trankle C; Thurber CJ; Toldo S; Abbate A
    JACC Basic Transl Sci; 2016 Oct; 1(6):524-535. PubMed ID: 30167535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular crosstalk in cardioprotection: Where and when do reactive oxygen species play a role?
    Martins-Marques T; Rodriguez-Sinovas A; Girao H
    Free Radic Biol Med; 2021 Jun; 169():397-409. PubMed ID: 33892116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process.
    Moens AL; Claeys MJ; Timmermans JP; Vrints CJ
    Int J Cardiol; 2005 Apr; 100(2):179-90. PubMed ID: 15823623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of microvascular reperfusion with adjunctive pharmacological intervention: its impact on myocardial perfusion and functional outcomes in patients with acute myocardial infarction.
    Taniyama Y; Ito H; Morishita R; Ogihara T
    Drugs; 2001; 61(4):437-41. PubMed ID: 11324678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury.
    Chin KY; Qin C; May L; Ritchie RH; Woodman OL
    Curr Drug Targets; 2017; 18(15):1689-1711. PubMed ID: 26424394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischaemic heart disease: clinical improvement with metabolic approach.
    Ferrari R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V7-20. PubMed ID: 11206104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries.
    Zhao T; Wu W; Sui L; Huang Q; Nan Y; Liu J; Ai K
    Bioact Mater; 2022 Jan; 7():47-72. PubMed ID: 34466716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
    Jaffe R; Dick A; Strauss BH
    JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury.
    Intachai K; C Chattipakorn S; Chattipakorn N; Shinlapawittayatorn K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.